NasdaqGS - Nasdaq Real Time Price USD
CG Oncology, Inc. (CGON)
20.42
+0.01
+(0.05%)
As of 11:15:56 AM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| DECHENG CAPITAL GLOBAL LIFE SCIENCES FUND IV, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase | Jan 29, 2024 | -- |
| DECHENG VENTURE CAPITAL LTD. Beneficial Owner of more than 10% of a Class of Security | Purchase | Jan 29, 2024 | -- |
| KASTURI VIJAY M.D. Officer | Purchase | Jan 29, 2024 | 1,315 |
| POST LEONARD E Director | Sale | Mar 17, 2025 | 0 |
| ROCHE CORLEEN M Chief Financial Officer | Purchase | Jan 29, 2024 | 2,000 |
| SONG HONG FANG Director | Sale | Dec 16, 2024 | -- |
Related Tickers
BCAX Bicara Therapeutics Inc.
13.05
+3.16%
SYRE Spyre Therapeutics, Inc.
13.28
-2.14%
UPB Upstream Bio, Inc.
9.71
0.00%
MBX MBX Biosciences, Inc.
8.14
+6.54%
CGEM Cullinan Therapeutics, Inc.
7.96
-1.73%
CYTK Cytokinetics, Incorporated
38.51
+1.53%
MLYS Mineralys Therapeutics, Inc.
13.02
-1.66%
IMCR Immunocore Holdings plc
28.73
-2.33%
EWTX Edgewise Therapeutics, Inc.
13.79
+3.65%
XNCR Xencor, Inc.
10.34
-2.45%